Clinical trial
Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
NCT00308971 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00308971 |
|---|---|
| Title | Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT) |
| Official title | Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT) |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Alpha, gamma, beta, and delta (mixed) tocopherols, alpha lipoic acid, placebo |
| Enrollment | 62 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Mar 30, 2006 |
| Last update posted | Jul 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: